MicroRNA-152 Regulates Endometrial Serous Carcinoma Cell Motility by Suppressing Matrix Metalloproteinase 10 Expression
Shogo Shigeta(Tohoku University), Nobuo Yaegashi(Tohoku University)
Cited by 3
Related Papers
Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma
|Molecular Cancer Therapeutics|2021|30
Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer
|Scientific Reports|2018|29
La-Related Protein 4 as a Suppressor for Motility of Ovarian Cancer Cells
|The Tohoku Journal of Experimental Medicine|2019|23
Novel cooperative pathway of c-Myc and Furin, a pro-protein convertase, in cell proliferation as a therapeutic target in ovarian cancers
|Oncotarget|2017|13
Amniotic LPS-Induced Apoptosis in the Fetal Brain Is Suppressed by Vaginal LPS Preconditioning but Is Promoted by Continuous Ischemic Reperfusion
|International Journal of Molecular Sciences|2022|2